Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Reference Values | 3 | 2026 | 211 | 1.330 |
Why?
|
| Antimalarials | 2 | 2024 | 64 | 0.990 |
Why?
|
| Drug Synergism | 2 | 2024 | 195 | 0.990 |
Why?
|
| Self-Help Devices | 1 | 2025 | 3 | 0.950 |
Why?
|
| Plasmodium falciparum | 2 | 2024 | 144 | 0.940 |
Why?
|
| CA-125 Antigen | 1 | 2024 | 11 | 0.870 |
Why?
|
| Hospital Mortality | 4 | 2020 | 210 | 0.860 |
Why?
|
| Artificial Intelligence | 2 | 2023 | 112 | 0.840 |
Why?
|
| Drug Combinations | 1 | 2024 | 104 | 0.810 |
Why?
|
| Ovarian Neoplasms | 2 | 2024 | 415 | 0.760 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2023 | 193 | 0.660 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 22 | 0.640 |
Why?
|
| Mitral Valve | 1 | 2020 | 36 | 0.640 |
Why?
|
| Computational Biology | 4 | 2023 | 327 | 0.610 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 49 | 0.600 |
Why?
|
| Humans | 26 | 2026 | 43102 | 0.450 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 74 | 0.420 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2021 | 110 | 0.410 |
Why?
|
| Puerto Rico | 4 | 2026 | 1413 | 0.400 |
Why?
|
| Biomedical Research | 3 | 2023 | 502 | 0.390 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2021 | 199 | 0.380 |
Why?
|
| Female | 16 | 2026 | 24698 | 0.350 |
Why?
|
| Aged | 8 | 2026 | 8214 | 0.340 |
Why?
|
| Algorithms | 3 | 2026 | 509 | 0.310 |
Why?
|
| Membrane Proteins | 2 | 2025 | 561 | 0.290 |
Why?
|
| Risk Assessment | 3 | 2019 | 863 | 0.270 |
Why?
|
| Proteomics | 3 | 2025 | 378 | 0.270 |
Why?
|
| Male | 12 | 2026 | 23409 | 0.270 |
Why?
|
| Treatment Outcome | 3 | 2019 | 1604 | 0.250 |
Why?
|
| Middle Aged | 7 | 2026 | 12222 | 0.240 |
Why?
|
| Pharmacogenetics | 1 | 2026 | 67 | 0.230 |
Why?
|
| Warfarin | 1 | 2026 | 67 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2025 | 108 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2025 | 105 | 0.220 |
Why?
|
| Anticoagulants | 1 | 2026 | 122 | 0.220 |
Why?
|
| Aryldialkylphosphatase | 1 | 2024 | 14 | 0.220 |
Why?
|
| Activities of Daily Living | 1 | 2025 | 139 | 0.220 |
Why?
|
| Nucleus Accumbens | 1 | 2025 | 100 | 0.220 |
Why?
|
| Hydrazones | 1 | 2024 | 11 | 0.210 |
Why?
|
| Autophagy | 1 | 2025 | 140 | 0.210 |
Why?
|
| Plasmodium berghei | 1 | 2024 | 34 | 0.210 |
Why?
|
| Extinction, Psychological | 1 | 2025 | 104 | 0.210 |
Why?
|
| Phosphoproteins | 1 | 2025 | 206 | 0.210 |
Why?
|
| Internet | 1 | 2025 | 236 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 1 | 2025 | 196 | 0.200 |
Why?
|
| United States | 5 | 2022 | 5205 | 0.200 |
Why?
|
| Drug Therapy, Combination | 1 | 2024 | 234 | 0.200 |
Why?
|
| Bayes Theorem | 2 | 2021 | 126 | 0.200 |
Why?
|
| Cannabinoids | 1 | 2024 | 73 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 291 | 0.190 |
Why?
|
| Malaria, Falciparum | 1 | 2024 | 90 | 0.190 |
Why?
|
| Ethanol | 1 | 2025 | 224 | 0.190 |
Why?
|
| Adult | 5 | 2026 | 13872 | 0.190 |
Why?
|
| Opioid-Related Disorders | 1 | 2026 | 195 | 0.190 |
Why?
|
| Fear | 1 | 2025 | 272 | 0.190 |
Why?
|
| Qualitative Research | 1 | 2025 | 574 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2024 | 863 | 0.180 |
Why?
|
| DNA Methylation | 1 | 2026 | 403 | 0.180 |
Why?
|
| SELEX Aptamer Technique | 1 | 2021 | 16 | 0.180 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 719 | 0.170 |
Why?
|
| Cisplatin | 1 | 2022 | 98 | 0.170 |
Why?
|
| Age Factors | 1 | 2024 | 1154 | 0.170 |
Why?
|
| Databases, Factual | 2 | 2019 | 341 | 0.170 |
Why?
|
| Aptamers, Nucleotide | 1 | 2021 | 51 | 0.170 |
Why?
|
| RNA, Messenger | 1 | 2025 | 1271 | 0.160 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 146 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 161 | 0.160 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2021 | 61 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2024 | 749 | 0.160 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 117 | 0.160 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2019 | 13 | 0.150 |
Why?
|
| Geography | 1 | 2019 | 110 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2022 | 307 | 0.150 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 33 | 0.140 |
Why?
|
| ras Proteins | 1 | 2019 | 54 | 0.140 |
Why?
|
| Burns | 1 | 2018 | 10 | 0.140 |
Why?
|
| Platelet Aggregation | 1 | 2018 | 21 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 2853 | 0.140 |
Why?
|
| Software | 2 | 2023 | 236 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 440 | 0.140 |
Why?
|
| HIV-1 | 1 | 2024 | 755 | 0.140 |
Why?
|
| Receptors, Immunologic | 1 | 2018 | 73 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 200 | 0.130 |
Why?
|
| Brain | 1 | 2026 | 1472 | 0.130 |
Why?
|
| Wound Healing | 1 | 2018 | 88 | 0.130 |
Why?
|
| Antifungal Agents | 1 | 2019 | 169 | 0.130 |
Why?
|
| Skin | 1 | 2018 | 187 | 0.130 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2024 | 241 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 306 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2022 | 968 | 0.120 |
Why?
|
| Primary Health Care | 1 | 2019 | 380 | 0.120 |
Why?
|
| Risk Factors | 2 | 2019 | 3994 | 0.100 |
Why?
|
| Nucleotides | 2 | 2024 | 37 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 590 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1019 | 0.100 |
Why?
|
| Haplotypes | 2 | 2024 | 197 | 0.090 |
Why?
|
| Placenta | 2 | 2022 | 117 | 0.080 |
Why?
|
| HIV Infections | 1 | 2024 | 2586 | 0.080 |
Why?
|
| Minority Groups | 2 | 2022 | 690 | 0.070 |
Why?
|
| Mice | 3 | 2025 | 6644 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 2676 | 0.060 |
Why?
|
| Pregnancy | 2 | 2022 | 1772 | 0.060 |
Why?
|
| 5-Methylcytosine | 1 | 2026 | 7 | 0.060 |
Why?
|
| Autopsy | 1 | 2026 | 48 | 0.060 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2025 | 50 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2026 | 149 | 0.050 |
Why?
|
| Plasmodium cynomolgi | 1 | 2024 | 4 | 0.050 |
Why?
|
| Plasmodium vivax | 1 | 2024 | 8 | 0.050 |
Why?
|
| Hep G2 Cells | 1 | 2024 | 63 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2024 | 77 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2024 | 91 | 0.050 |
Why?
|
| Exocytosis | 1 | 2024 | 49 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2024 | 77 | 0.050 |
Why?
|
| Lysosomes | 1 | 2024 | 86 | 0.050 |
Why?
|
| Writing | 1 | 2023 | 42 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2023 | 79 | 0.050 |
Why?
|
| Malaria | 1 | 2024 | 90 | 0.050 |
Why?
|
| Cystatin B | 1 | 2022 | 11 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2025 | 986 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 120 | 0.050 |
Why?
|
| Minority Health | 1 | 2022 | 95 | 0.050 |
Why?
|
| Faculty | 1 | 2022 | 105 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2022 | 41 | 0.050 |
Why?
|
| Language | 1 | 2023 | 185 | 0.040 |
Why?
|
| Decision Trees | 1 | 2021 | 22 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2021 | 24 | 0.040 |
Why?
|
| Gene Library | 1 | 2021 | 62 | 0.040 |
Why?
|
| Natural Language Processing | 1 | 2021 | 21 | 0.040 |
Why?
|
| Animals | 3 | 2025 | 16992 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2023 | 423 | 0.040 |
Why?
|
| Research Personnel | 1 | 2022 | 206 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2022 | 189 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2024 | 358 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 78 | 0.040 |
Why?
|
| Young Adult | 2 | 2024 | 5080 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2021 | 65 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 374 | 0.040 |
Why?
|
| Metabolomics | 1 | 2021 | 95 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 131 | 0.040 |
Why?
|
| Cytokines | 1 | 2024 | 678 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 388 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 152 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2021 | 182 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 1869 | 0.040 |
Why?
|
| Macrophages | 1 | 2024 | 529 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 934 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2019 | 27 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 861 | 0.040 |
Why?
|
| Mutation | 1 | 2024 | 1177 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2019 | 104 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 2018 | 9 | 0.040 |
Why?
|
| Logistic Models | 1 | 2021 | 1009 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 78 | 0.040 |
Why?
|
| Clone Cells | 1 | 2018 | 50 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2018 | 48 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2018 | 127 | 0.030 |
Why?
|
| Immunization | 1 | 2018 | 94 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2024 | 1003 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2019 | 245 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 1082 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 735 | 0.030 |
Why?
|
| Rabbits | 1 | 2018 | 278 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 229 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2018 | 81 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 758 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2019 | 263 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 704 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2018 | 883 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2022 | 1455 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 1180 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2019 | 876 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 701 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 372 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 1612 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1857 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3156 | 0.030 |
Why?
|
| Child | 1 | 2019 | 3443 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 6081 | 0.020 |
Why?
|